|
KMID : 1039120240130020073
|
|
Clinical and Experimental Vaccine Research
2024 Volume.13 No. 2 p.73 ~ p.82
|
|
|
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
|
|
Christopher Oelkrug
|
|
|
Abstract
|
|
|
|
DNA cancer vaccines as an approach in tumor immunotherapy are still being investigated in preclinical and clinical settings. Nevertheless, only a small number of clinical studies have been published so far and are still active. The investigated vaccines show a relatively stable expression in in-vitro transfected cells and may be favorable for developing an immunologic memory in patients. Therefore, DNA vaccines could be suitable as a prophylactic or therapeutic approach against cancer. Due to the low efficiency of these vaccines, the administration technique plays an important role in the vaccine design and its efficacy. These DNA cancer vaccine delivery systems include physical, biological, and non-biological techniques. Although the pre-clinical studies show promising results in the application of the different delivery systems, further studies in clinical trials have not yet been successfully proven.
|
|
|
KEYWORD
|
|
|
Vaccines, DNA, Oncology, Immunotherapy, Vaccination, Delivery
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|